DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on December 2, 2005; DOI: 10.1124/dmd.105.007807


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.007807v1
34/3/389    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anand, S. S
Right arrow Articles by Bruckner, J. V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anand, S. S
Right arrow Articles by Bruckner, J. V


Received for publication October 11, 2005.
Revised November 30, 2005.
Accepted for publication November 30, 2005.

ONTOGENY OF HEPATIC AND PLASMA METABOLISM OF DELTAMETHRIN IN VITRO: ROLE IN AGE-DEPENDENT ACUTE NEUROTOXICITY

Sathanandam S Anand 1*, Kyu-Bong Kim 1, Stephanie Padilla 2, Srinivasa muralidhara 1, Hyo J Kim 1, Jeffrey W Fisher 1, James V Bruckner 1

1 University of georgia 2 US EPA

* Address correspondence to: E-mail: sanand{at}rx.uga.edu

Abstract

Deltamethrin (DLM) is a relatively potent and widely used pyrethroid insecticide. Inefficient detoxification has been proposed to be the primary reason for the greater sensitivity of immature rats to DLM acute neurotoxicity. The objective of this study was to test this hypothesis by characterizing the age-dependency of DLM metabolism in vitro, as well as toxic signs and blood levels of the neurotoxic parent compound following administration of 10 mg DLM/kg po in glycerol formal. Metabolism was quantified in vitro by monitoring disappearance of the parent compound from plasma [via carboxylesterases (CaEs)] and liver microsomes [via CaEs and cytochome P450s (CYPs)] obtained from 10-, 21- and 40-d-old (PND) male Sprague-Dawley rats. Mean (±SE) intrinsic clearances (Vmax/Km) in these respective age-groups by liver CYPs (4.99±0.32, 16.99±1.85 and 38.45±7.03) and by liver CaEs (0.34±0.05, 1.77±0.38 and 2.53±0.19) and plasma CaEs (0.39±0.06, 0.80±0.09 and 2.28±0.56) increased significantly (p≤0.05) with age, due to progressive increases in Vmax. Intrinsic clearance of DLM by plasma CaEs and liver CYPs reached adult levels by 40 d, but clearance by liver CaEs did not. Hepatic CYPs played the predominant role in DLM biotransformation in young and adults. The incidence and severity of neurotoxic effects varied inversely with age. Correspondingly, blood DLM AUCs and Cmaxs progressively decreased with increasing age. Internal exposure to DLM (blood AUCs) was closely correlated with toxic signs (salivation and tremors). The present study provides evidence that immature rats' limited metabolic capacity contributes to elevated systemic exposure and ensuing neurotoxic effects of DLM.


Key words: carboxylesterases, cytochrome P450, developmental toxicology, enzyme kinetics, insecticides


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
H.-J. Zhu and J. S. Markowitz
Activation of the Antiviral Prodrug Oseltamivir Is Impaired by Two Newly Identified Carboxylesterase 1 Variants
Drug Metab. Dispos., February 1, 2009; 37(2): 264 - 267.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. J. Scollon, J. M. Starr, S. J. Godin, M. J. DeVito, and M. F. Hughes
In Vitro Metabolism of Pyrethroid Pesticides by Rat and Human Hepatic Microsomes and Cytochrome P450 Isoforms
Drug Metab. Dispos., January 1, 2009; 37(1): 221 - 228.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Alcorn, F. A. Elbarbry, M. Z. Allouh, and P. J. McNamara
Evaluation of the Assumptions of an Ontogeny Model of Rat Hepatic Cytochrome P450 Activity
Drug Metab. Dispos., December 1, 2007; 35(12): 2225 - 2231.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.